South Korean Pharmaceuticals & Biotech Most Popular Stocks

CG Invites

Market Cap: ₩126.1b

A biopharma company, engages in the discovery and development of structural chemoproteiomics-based drugs in Korea.

Ildong Holdings

Market Cap: ₩122.5b

Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.

Aprogen Biologics

Market Cap: ₩120.1b

Manufactures and sells pharmaceutical products primarily in South Korea.

Hyundai ADM Bio

Market Cap: ₩118.1b

A contract research organization, provides clinical services in Asia.

ENCell

Market Cap: ₩118.1b

Develops cell/gene-based biopharmaceutical products in South Korea.

iNtRON Biotechnology

Market Cap: ₩116.8b

Engages in the development of novel drugs in South Korea.

HLB bioStepLtd

Market Cap: ₩113.4b

Provides various test services.

KoBioLabs

Market Cap: ₩111.5b

Provides microbiome therapeutics for metabolic, immune, and neurological diseases.

NanoEntek

Market Cap: ₩111.4b

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

Cellid

Market Cap: ₩109.6b

Develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies.

Oncocross

Market Cap: ₩108.2b

Develops drugs for the treatment of cancers, rare diseases, and intractable diseases in South Korea.

Hyundai Pharmaceutical

Market Cap: ₩106.7b

Manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally.

Dx & Vx

Market Cap: ₩105.6b

Engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea.

Sam-A Pharm

Market Cap: ₩102.8b

Operates as a pharmaceutical company in South Korea.

Theragen EtexLtd

Market Cap: ₩100.0b

Engages in the research and development, production, and sale of pharmaceutical products in Korea.

Hwail PharmaceuticalLtd

Market Cap: ₩96.9b

Develops pharmaceutical raw materials in South Korea.

Daehan NupharmLtd

Market Cap: ₩96.4b

Manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally.

DreamCIS

Market Cap: ₩92.8b

Provides clinical research services in South Korea.

WITHUS PHARMACEUTICALLTD

Market Cap: ₩92.3b

Engages in the production and sale of pharmaceutical products in South Korea.

curacleltd

Market Cap: ₩92.0b

Curacle Co., Ltd., a bio-venture business, engages in the research and development of drugs for diseases caused by aging process and damage to blood vessels.

Polaris AI Pharma

Market Cap: ₩91.4b

Engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally.

Choong Ang Vaccine Laboratory

Market Cap: ₩90.4b

Operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea.

PharmAbcine

Market Cap: ₩88.0b

PharmAbcine Inc., a clinical-stage biotech company, develops human therapeutic monoclonal antibody (mAb) for the treatment of neovascular disorders, tumors, and other medically unmet diseases.

Kukje Pharma

Market Cap: ₩88.8b

Engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products.

Ahn-Gook Pharmaceutical

Market Cap: ₩88.1b

Manufactures and sells pharmaceutical products.

GL Pharm Tech

Market Cap: ₩87.9b

Provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea.

Progen

Market Cap: ₩86.2b

A biotechnology company, engages in platform-based drug discovery and development activities.

Cell Biotech

Market Cap: ₩85.7b

A biotechnology company, develops lactic acid bacteria products in South Korea and internationally.

Sinsin Pharmaceutical

Market Cap: ₩84.5b

Manufactures and sells pharmaceutical products in South Korea.

Enzychem Lifesciences

Market Cap: ₩84.2b

Engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea.

Genome

Market Cap: ₩83.9b

A clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea.

Naturalendo Tech

Market Cap: ₩83.7b

Engages in the research, development, manufacture, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea.

PharmGen Science

Market Cap: ₩81.2b

Engages in the research and development, production, and sale of pharmaceutical products in South Korea.

P&K Skin Research Center

Market Cap: ₩80.9b

Engages in the evaluation and research of dermatological products in South Korea.

QuantaMatrix

Market Cap: ₩80.6b

Operates as an in-vitro diagnostics company in South Korea.

PanGen Biotech

Market Cap: ₩80.2b

Operates as a biologics company in South Korea.